Science
Mechanism of Action
This extract, predominantly comprising exosomes and conditioned media from human neural stem cells, operates via multiple pathways. It actively promotes fibroblast migration and angiogenesis, crucial for efficient wound healing. Key neurotrophic factors and immunity-related proteins within the extract support immunomodulation and regenerative processes. Furthermore, it is rich in various growth factors (such as bFGF, EGF, TGF-β1, HGF, VEGF), collagen, fibronectin, and antioxidant enzymes like SOD, which collectively stimulate fibroblast activity, boost collagen synthesis, inhibit melanin production, and provide broad anti-inflammatory and antioxidant benefits leading to comprehensive skin rejuvenation.
Research
Clinical Evidence
High confidenceN/A
Key findings
- 01 Exosomes derived from human induced neural stem cells promoted human dermal fibroblast migration and human umbilical vein endothelial cell tube formation in vitro, significantly enhancing wound healing in a mouse skin injury model.
- 02 Topical application of stem cell conditioned media, which can contain secretions from neural cells, has been clinically shown to significantly reduce wrinkles, pigmentation, and skin pores.
- 03 A split-face clinical trial assessed a topical gel with hypoxically cultured human neonatal cell conditioned media, observing significant, dose-dependent improvements in post-laser wound healing, alongside reductions in transepidermal water loss and inflammation.
- 04 An extract was reported to elevate emotional dimensions of relaxation, balance, and calmness in volunteers under stress, while simultaneously enhancing the skin's radiant appearance.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
While specific stability data for the 'extract' in cosmetic formulations is limited, the active components, predominantly aqueous, are often stable for approximately 4 weeks when stored at 2-8°C in the dark within cell culture media.
Safety
Safety Profile
This ingredient has not been reviewed by the Cosmetic Ingredient Review (CIR) or Scientific Committee on Consumer Safety (SCCS). The FDA has not approved exosome products for cosmetic uses, and currently only authorizes blood-forming stem cell products for specific medical disorders. The use of human cells and their derivatives in cosmetics raises significant ethical considerations and potential safety risks due to regulatory ambiguity and the biological nature of the material.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While exhibiting potent regenerative and anti-aging benefits in clinical studies, the lack of regulatory review, ethical considerations, and potential safety risks associated with human-derived materials necessitate caution.
Related
Similar Ingredients
Finding similar ingredients…